Pneumocandin B0
Generic Name: pneumocandin b0
Dosage form: POWDER. Active ingredients: PNEUMOCANDIN B0 (1 kg/kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: PNEUMOCANDIN B0 (1 kg/kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Apium Graveolens, Salvia Officinalis
apium graveolens, salvia officinalis
Non-Standardized Plant Allergenic Extract [EPC]
Purpose Apium graveolens - 6C HPUS (soporific active principle) Salvia officinalis - 6C HPUS (insomnia and night sweats) The letters ‘HPUS’ indicate that the components in this product are officially monographed in the Homoeopathic Pharmacopoeia of the United States
Bevacizumab-bvzr
bevacizumab-bvzr
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-bvzr is a vascular endothelial growth factor inhibitor. Bevacizumab-bvzr is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-bvzr has an approximate molecular weight of 149 kDa. Bevacizumab-bvzr is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Nifurtimox
nifurtimox
11 DESCRIPTION LAMPIT contains nifurtimox, an antiprotozoal. The chemical name is (E)-N-(3-Methyl-1,1-dioxidothiomorpholin-4-yl)-1-(5-nitro-2-furyl)methanimine. The molecular weight is 287.29 and the molecular formula is C 10 H 13 N 3 O 5 S. The structural formula is: LAMPIT (nifurtimox) tablets are yellow round, biconvex tablets, each containing 30 mg or 120 mg of nifurtimox, intended for oral use. The 30 mg tablets are functionally scored on one side and marked with ‘30’ on the other side.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.